DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20194757

Is that a scolex? a case of clinically isolated syndrome

Van K. Ma, Lourdemillard Bellevue, Maria Espiritu Fuller

Abstract


Clinically Isolated Syndrome is an initial demyelinating event of the central nervous system that has been associated with the future development of multiple sclerosis. Diagnostic studies include clinical and paraclinical studies. Patients with lesions on MRI of the brain at baseline will more likely develop multiple sclerosis compared to patients without findings. We report a case of a 10-year-old female of Colombian ancestry and origin, who presented with indiscernible neurological clinical signs and symptoms, with MRI brain with and without contrast showing demyelinating lesions with one lesion “suggesting” a scolex.


Keywords


Cysticercosis, Clinically isolated syndrome, Encephalopathy, Multiple sclerosis, Neurocysticercosis, Scolex

Full Text:

PDF

References


Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005 May 1;4(5):281-8.

Novakova L, Skoog B, Runmarker B, Ekholm S, Winblad S, Lisovskaja V, et al. Clinically isolated syndromes with no further disease activity suggestive of multiple sclerosis at the age of population life expectancy. Mult Scler J. 2014 Apr;20(4):496-500.

Sako Y, Takayanagui OM, Odashima NS, Ito A. Comparative study of paired serum and cerebrospinal fluid samples from neurocysticercosis patients for the detection of specific antibody to Taenia solium immunodiagnostic antigen. Trop Medi Health. 2015;43:173-6.

Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. New Eng J Medi. 2000 Nov 16;343(20):1430-8.

Dalton CM, Brex PA, Miszkiel KA, Hickman SJ, MacManus DG, Plant GT, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol: Official J Am Neurol Assoc Child Neurol Soc. 2002 Jul;52(1):47-53.

Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. New Eng J Medi. 2002;346(3):158-64.

Zipoli V, Hakiki B, Portaccio E, Lolli F, Siracusa G, Giannini M, et al. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis. Mult Scler J. 2009 Apr;15(4):472-8.

Sellebjerg F, Jensen CV, Christiansen M. Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis. J Neuroimmunol. 2000 Aug 1;108(1-2):207-15.

Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medi. 1999 Feb;5(2):170.

Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. New Eng J Medi. 2003 Jul 10;349(2):139-45.